Intra Cellular Therapies

Ebitda Changement Date
Acadia Pharmaceuticals USD 36.58M 92.63M 2023-12
ALKERMES USD 68.51M 189.7M 2023-09
Biogen USD 652.1M 241.8M 2023-12
Bristol-Myers Squibb USD 4.89B 261M 2023-12
Cytokinetics USD -121083000 672K 2023-12
Esperion Therapeutics USD -27507000 9.5M 2023-09
Gilead Sciences USD 2.73B 579M 2023-12
Halozyme Therapeutics USD 121.73M 10.37M 2023-12
Intra Cellular Therapies USD -33961000 4.38M 2023-12
Marinus Pharmaceuticals USD -31504000 192K 2023-09
Minerva Neurosciences USD -6071000 1.56M 2023-09
Nektar Therapeutics USD -31809000 70K 2023-09
Neurocrine Biosciences USD 146.7M 68M 2023-09
RedHill Biopharma USD -3813000 93.38M 2023-06
Supernus Pharmaceuticals USD 40.87M 10.87M 2023-12
United Therapeutics USD 277.4M 62.9M 2023-12
Vanda Pharmaceuticals USD -2489000 5.16M 2023-06



Intra Cellular Therapies - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.